In the SARS-CoV-2 era, do we need to be afraid of obinutuzumab?
{{output}}
In their paper, Pinto et al. report findings from the Italian URBAN study; an ambispective, observational, multicentre study evaluating the safety and efficacy of obinutuzumab-based therapy for advanced stage follicular lymphoma (FL) in routine practice. The U... ...